Cell Line : HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA]
Cellosaurus Index : CVCL_2914
Cellosaurus ID : HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA]
CTRP1 Name
, CTRP2 Name
, GDSC1 Name
, GDSC2 Name
: HARA
CCLE Name
: HARA_LUNG
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | (-)-gallocatechin-3-monogallate | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 123138 | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 123829 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 150412 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 16-beta-bromoandrosterone | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 16,16-dimethylprostaglandin-E2 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 2-bromopyruvate | CTRP1 | 0.2603 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 2-deoxyglucose | CTRP1 | 0.2890 | 37.0080 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 2-fluoropalmitic acid | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 2,4-dideoxy-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 3-chloro-L-alanine | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 4-methylfasudil | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 5-benzyl-9-tert-butyl-paullone | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 50869 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 6-diazo-5-oxo-L-norleucine | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 6-NBDG | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 615590 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 630600 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 667880 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 7-nitroindazole | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 720427 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 729189 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 741909 | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 743380 | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 765771 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 776928 | GDSC2 | 0.0300 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 968 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AA-COCF3 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ABH | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ABT-751 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ABT737 | GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AC55649 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Acetalax | GDSC2 | 0.0300 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Afatinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AGK-2 | GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Alda-1 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Alisertib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Alpelisib | GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | alpha-cyano-4-hydroxycinnamic acid | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AM-580 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ASN 05257430 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | aspirin | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AT7867 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | austocystin D | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | avrainvillamide | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Axitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZ-3146 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD-7545 | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD1208 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD1332 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD2014 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD4547 | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD5153 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD5438 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD5991 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD6482 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD7762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD8055 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | batimastat | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bax channel blocker | CTRP2,CTRP1 | 0.0160 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BDF00022089a | GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BDILV000379a | GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BDOCA000347a | GDSC2 | 0.0020 | 2.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BEC | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BEN | GDSC2 | 0.0300 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bexarotene | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BI-2536 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BIBR-1532 | GDSC2,CTRP2 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | bistramide A | CTRP1 | 0.2517 | 32.2330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BIX-01294 | CTRP2,CTRP1 | 0.0160 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BIX-01338 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | blebbistatin | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bleomycin | GDSC1,GDSC2 | 0.0020 | 64.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BMS-191011 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BMS-270394 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BMS-345541 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BMS-536924 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BMS-641988 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BMS-754807 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bortezomib | GDSC2,CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bosutinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | bovinocidin | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-A94377914 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K02492147 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K03536150 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K03911514 | CTRP2 | 0.0020 | 17.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K04800985 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K09587429 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K13185470 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K13999467 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K16130065 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K16147474 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K17060750 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K20514654 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K27188169 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K27188169:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K27224038 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K27986637 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K29086754 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K30019337 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K33199242 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K34099515 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K34222889 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K34485477 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K35604418 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K41334119 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K41597374 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K44224150 | CTRP2 | 0.0010 | 34.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K48334597 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K49290616 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K52037352 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K58730230 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K75293299 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K78574327 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K79669418 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K84807411 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K86535717 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K96431673 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K96970199 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD-K99584050 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD2649 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD4770 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD55319 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD63610 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD6368 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD7137 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD9786 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | brefeldin A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bromosporine | GDSC2 | 0.0020 | 2.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Cabozantinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | capsaicin | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 47.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Carmustine | GDSC2 | 0.0300 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CAY10594 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CD-1530 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CD-437 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CDK9_5038 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CDK9_5576 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | cerulenin | CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ch-55 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CHEMBL1222381 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CHEMBL374350 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CHEMBL399379 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CHIR-99021 | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CI-976 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ciclosporin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CIL41 | CTRP2 | 0.0049 | 160.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CIL55 | CTRP2 | 0.0003 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CIL55A | CTRP2 | 0.0024 | 80.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CIL56 | CTRP2 | 0.0001 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CIL70 | CTRP2 | 0.0012 | 40.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | cimetidine | CTRP2 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Cisplatin | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 10b | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 110 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 12 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 1541A | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 2 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 23 citrate | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 4 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 44 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Compound 7d-cis | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Crizotinib | GDSC2,CTRP2,CCLE | 0.0010 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | cyanoquinoline 11 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Cyclophosphamide | GDSC2,CTRP2 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | cytochalasin B | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | cytosporone B | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dacarbazine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dactinomycin | GDSC2 | 0.0000 | 0.8000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | dalcetrapib | CTRP1 | 0.2587 | 33.1000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Daporinad | GDSC1,GDSC2,CTRP2 | 0.0000 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | darinaparsin | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dasatinib | GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | dexamethasone | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | DG-041 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | dichloroacetic acid | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dihydrorotenone | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | DL-TBOA | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Docetaxel | GDSC1,GDSC2 | 0.0000 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Doramapimod | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Doxorubicin | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | eflornithine | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Eg5_9814 | GDSC2 | 0.0001 | 0.1000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ELCPK | CTRP2 | 0.0000 | 0.4000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Elephantin | GDSC2 | 0.0200 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Entinostat | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ERK_2440 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ERK_6604 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Erlotinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ethylidene glucose | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | etomoxir | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Etoposide | GDSC1,CTRP2 | 0.0009 | 28.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | fatostatin | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Fedratinib | GDSC1,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FGIN-1-27 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Fludarabine | GDSC2 | 0.0200 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | fluoropyruvate | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FMK-PA | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Foretinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | fosfomycin | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FQI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FSC231 | CTRP2 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Fulvestrant | GDSC1,GDSC2,CTRP2 | 0.0010 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | fumagillol | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Gallibiscoquinazole | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Gefitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Gemcitabine | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0001 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | glibenclamide | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Gly-Gly-PALO | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GMX-1778 | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | gossypol | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK-LSD1 | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK2110183B | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK2256098C | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK2276186C | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK269962A | GDSC1 | 0.0195 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK2801 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK2830371A | GDSC2 | 0.0030 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK3337463A | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK343 | GDSC2 | 0.0010 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK626616AC | GDSC2 | 0.0001 | 0.1000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GW-405833 | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | I-BET-762 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | I-BET151 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IAP_5620 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IC-87114 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | idarubicin | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Idelalisib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ifosfamide | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IGF1R_3801 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | indisulam | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IRAK4_4710 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Irinotecan | GDSC2 | 0.0050 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | iso-DC-45-A2 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | isoliquiritigenin | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | itraconazole | CTRP2,CTRP1 | 0.0005 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JAK_8517 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JAK1_8709 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JQ1 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | JZL-184 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | kinetin riboside | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KU-55933 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KU-60019 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | L-685458 | CTRP2,CTRP1,CCLE | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | L-Oxonoreleagnine | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Lapatinib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LE-135 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Lenalidomide | GDSC1,GDSC2,CTRP1 | 0.0100 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | leucascandrolide A | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LGK974 | GDSC1,GDSC2 | 0.0050 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Linifanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Linsitinib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LMB_AB1 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LMB_AB2 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LMB_AB3 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LMP744 | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | lonidamine | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | losartan | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | lovastatin acid | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Luminespib | GDSC1,GDSC2 | 0.0003 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LY-2157299 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LY-2183240 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LY-2365109 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | LY2109761 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | m-3M3-FBS | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | maraviroc | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Masitinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Merck60 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Methotrexate | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MG-132 | GDSC2 | 0.0156 | 4.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Mitoxantrone | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MK-1775 | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MK-2206 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MK-591 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML006 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML007 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML013 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML030 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML037 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML038 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML039 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML050 | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML101 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML203 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML258 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML312 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | myriocin | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N-oxalyl-D-phenylalanine | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | N5-iminoethyl-L-ornithine | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | nakiterpiosin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Navitoclax | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | necrostatin-1 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Nelarabine | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | neopeltolide | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | nifedipine | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Nilotinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC 74859 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC23766 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC632839 | CTRP2,CTRP1 | 0.0160 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NSC95397 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Nutlin-3a | CTRP1,CCLE,GDSC1,GDSC2,CTRP2 | 0.0025 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NVP-ADW742 | GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Obatoclax Mesylate | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Olaparib | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0045 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | oligomycin A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | OSI-027 | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | OSI-930 | GDSC1,CTRP2 | 0.0020 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | OSW-1 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Oxaliplatin | GDSC2,CTRP2 | 0.0100 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | oxythiamine | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PAC-1 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Paclitaxel | GDSC2,CTRP2,CCLE | 0.0000 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PAK_5339 | GDSC2 | 0.0300 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Palbociclib | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | pandacostat | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | panduratin A | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Panobinostat | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Parthenolide | CTRP2,CTRP1 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Pazopanib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PD0325901 | GDSC1,GDSC2,CCLE | 0.0003 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Pemetrexed | GDSC1,CTRP1 | 0.0100 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Pevonedistat | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PF-3845 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PF-4708671 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PF-750 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PHA-793887 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | phloretin | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PI-103 | GDSC1,CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Pictilisib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | pifithrin-mu | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PIK-75 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PIK-93 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Piperlongumine | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | pluripotin | CTRP2,CTRP1 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PLX-4720 | GDSC1,GDSC2,CTRP2,CCLE | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Podophyllotoxin bromide | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PP-30 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PRIMA-1 | CTRP2,CTRP1 | 0.0051 | 170.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PRIMA-1MET | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PRL-3 Inhibitor I | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PT-630 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | purmorphamine | CTRP2,CTRP1 | 0.0046 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | QS11 | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | quinoclamine | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Quizartinib | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | racemic-2,4-dideoxy-DC-45-A2 | CTRP1 | 0.2890 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Rapamycin | GDSC2,CTRP2,CTRP1 | 0.0000 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Regorafenib | CTRP2 | 0.0320 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | RepSox | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | RG-108 | CTRP2,CTRP1 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | RITA | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ro-28-1675 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Romidepsin | GDSC2 | 0.0000 | 0.0100 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | rosiglitazone | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | rotenone | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ruxolitinib | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Sapitinib | GDSC2 | 0.0050 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SB-225002 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SB216763 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SCH-79797 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Schweinfurthin A | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Selisistat | GDSC1,CTRP2 | 0.0024 | 80.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Selumetinib | GDSC1,GDSC2,CTRP2,CCLE | 0.0025 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 200.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Sepantronium bromide | GDSC1,GDSC2,CTRP2 | 0.0000 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Serdemetan | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SGC-CBP30 | GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SID 26681509 | CTRP2,CTRP1 | 0.0090 | 300.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | sildenafil | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | simvastatin | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Sinularin | GDSC2 | 0.0030 | 3.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | sitagliptin | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SJ-172550 | CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SKI-II | CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SN-38 | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0000 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SNS-032 | CTRP2 | 0.0020 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SNX-2112 | GDSC1,CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Sorafenib | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | sparfosic acid | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Sphingosine Kinase 1 Inhibitor II | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SR-II-138A | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Staurosporine | GDSC2,CTRP2 | 0.0001 | 3.3000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | StemRegenin 1 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | SU11274 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | T-5345967 | CTRP2,CTRP1 | 0.0160 | 530.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tacrolimus | CTRP2,CTRP1 | 0.0023 | 74.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TAF1_5496 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Tamoxifen | GDSC1,GDSC2,CTRP2 | 0.0030 | 100.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Tanespimycin | CTRP1,CCLE,GDSC1,GDSC2,CTRP2 | 0.0010 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Taselisib | GDSC2 | 0.0040 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Telomerase Inhibitor IX | GDSC2,CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Temozolomide | GDSC1,GDSC2,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Temsirolimus | GDSC1,GDSC2,CTRP2 | 0.0008 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Teniposide | GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TGX-115 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tigecycline | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tipifarnib-P1 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tipifarnib-P2 | CTRP2,CTRP1 | 0.0010 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Tivozanib | GDSC1,CTRP2 | 0.0005 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Topotecan | GDSC2,CTRP2,CCLE | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Tozasertib | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TPCA-1 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Tretinoin | GDSC1,CTRP2,CTRP1 | 0.0041 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | triacsin C | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | trifluoperazine | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | triptolide | CTRP2,CTRP1 | 0.0000 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Tubastatin A | GDSC1,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TW 37 | GDSC1,GDSC2,CTRP2 | 0.0010 | 8.3000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ubistatin B | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ULK1_4989 | GDSC2 | 0.0300 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | UNC0638 | GDSC1,GDSC2,CTRP2 | 0.0010 | 40.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | valdecoxib | CTRP2,CTRP1 | 0.0180 | 600.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Veliparib | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VER-155008 | CTRP2,CTRP1 | 0.0011 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Vincristine | GDSC2,CTRP2 | 0.0030 | 130.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Vismodegib | GDSC1,GDSC2,CTRP1 | 0.0100 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Vorinostat | GDSC1,GDSC2,CTRP2,CTRP1 | 0.0010 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0320 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VSP34_8731 | GDSC2 | 0.0300 | 30.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Wee1 Inhibitor | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WT-161 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | XAV939 | GDSC1,GDSC2,CTRP1 | 0.0100 | 37.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | YK-4-279 | GDSC1,GDSC2,CTRP2 | 0.0010 | 33.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | YM-022 | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | zebularine | CTRP2,CTRP1 | 0.0180 | 590.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | zileuton | CTRP1 | 0.2603 | 33.3330 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ZM447439 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | Zoledronate | GDSC2 | 0.0020 | 2.0000 |
|
| HARA[HUMANSQUAMOUSCELLLUNGCARCINOMA] | ZSTK474 | GDSC1,CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC